Hardboy
10 Nov 2016
Re: Disappointed Fred, for a share holder you seem remarkably keen for the share price to fall. "Reading between the lines, the RNS this morning seems like management are keeping their cards close to their chest," - I would say on the contrary. It's a bog standard quarterly update, and looking at the figures I doubt they are hiding anything, so "how well Hikma are actually doing" is there for all to see. FY sales of $2b is very impressive growth; but I can't help thinking looking at their figures it's about vanity rather than sanity, i.e. they are growing sales at the expense of profits; and profits are what really matter. Hopefully their strategy is good and the profits will flow more freely as their businesses mature. They've only been listed on the LSE for 11 years. it's a family business, so why would they want the hassle of taking it private again? I don't see that as a scenario. enlarge rich Jordanians love the prestige of being FTSE 100 directors. That's the mentality; so I would be very surprised if they were taking the company private; and if the share price is being driven lower on their instructions, why would they have spent so much buying shares at higher prices? No I think you're looking for strategies where they don't exist. A potential take-over bid is possible; but any potential bidder must know they have to come up with a price to persuade the directors, and they will know at what price they have recently bought shares; so their driving the price lower is of no real benefit; unless it is to hoover up shares on the open market at lower prices, but then we would have seen an increase in volume. So, sorry Fred, I don't think those theories carry much weight.
Fred Prior
10 Nov 2016
Health care up 3.5% most Pharmas showing green today..........except, you guessed it...Hikma LOLMaybe Fred still can buy sub 1500p, come on Gayfair funds, pull your finger out and start flipping the shares, you know you want to, just make sure you manage to fill my order before reversing!
Fred Prior
10 Nov 2016
Disappointed that we never had an over exaggerated drop on the open, was counting on bagging a few sub 1500p, still theres always time yet I suppose.Reading between the lines, the RNS this morning seems like management are keeping their cards close to their chest, its almost as if things at Hikma have been talked down a little. One could almost think and particularly as the SP is so low at present and the fact insiders have purchased lots of shares at much higher prices than of current, there are two scenarios in my train of thought, could it be that a predator is stalking and if they knew really just how well Hikma were actually doing it would make them go hostile at these lowly prices? I mean a 25% premium on the current price would only equate to just over 2100p, less than where the price was when the Directors were throwing millions buying up stock, that coupled with the fact that they are very close to the 30% mark, can only be either for a blocking reason should the opportunistic bidder pounce or they want to do a management buyout and take it private and after buying a chunk higher up they have instructed an institution/s to get the share price lower so that if they take the company private they get it on the cheap?They say the Market is always ahead on these situations and that could be the reason why the analysts are keeping quiet whilst the games are being played with the SP and also the recent short positions and intervention from the hedge funds.The plot thickens, the share price is showing a text book pattern of a company that is in the throes of being taken out.Interesting times ahead, one way or the other.
Ravinell
10 Nov 2016
Re: The SPs fate is already sealed So nothing very interesting then. I diagnose some indigestion and concomitant constipation. I shall continue to watch from the sidelines for the time being.
Hardboy
10 Nov 2016
Re: The SPs fate is already sealed 8
0 was always going to be interesting as we have the last quarter's figures in. Bit of a mix of good & bad. Growth is strong; but profits under a bit of pressure. The Injectables business seems to be the shining light. The other 2 divisions are struggling a bit, but a medium to longer term view on Generics looks very positive.
Openwoe
10 Nov 2016
Re: The SPs fate is already sealed All very cryptic - anything more tangible Fred?
Fred Prior
09 Nov 2016
The SPs fate is already sealed 8am is going to be interesting so I am informed,
Fred Prior
09 Nov 2016
It would be nice if this tanks tomorrow as I have lots of powder dry to mop some up in the event, I am a buyer down to 1000p.Lets see what the Gayfair girls do with their shorts, I mean blouses tomorrow.Would be heaven to get my average down to 1200p!!!
bamboozled
09 Nov 2016
Re: Trump victory the catalyst? About 48% of HIK's revenue comes from US so probably Trump victory is seen as better option-at least a bit of respite from Clinton's drug cost lowering policies which could have been.
Openwoe
09 Nov 2016
Re: Good morning gents and ladies If you check the similar increase in Shire - I would suggest it is probably the former.
Hardboy
09 Nov 2016
Re: Good morning gents and ladies In terms of proving a conspiracy of course it is now not clear how much of today's bounce is due to a Trump win & how much due to unwinding shorts ahead of tomorrow's update.
Fred Prior
09 Nov 2016
Good morning gents and ladies well, that has put an end to the price is sliding because "Clinton will penalise Pharmas"Lets see what the Gayfair boys and their Yanky shorter do now.Lots of buying back to do girls, best you start now......oh and thats a heads up for you.Good day to all.Frederick.
YP Junior
09 Nov 2016
Trump victory the catalyst? If this share is being shorted (not convinced fully myself) then could Trumps victory be the catalyst for a substantial bounce.Fears over a Hilary win would no doubt have put pressure on the SP. Its just a shame the rest of the market wont take a liking to his victory. Prepare for a volatile few weeks on the markets as a whole
villafan1
09 Nov 2016
Re: Good Motley Fool review. Agreed, Hardboy. My attention was won over by the headline! I used to really rate MF. But the last few years they seem to flood the news feeds (certainly so on Yahoo Finance) with numerous, contradictory articles and opinion, so I tend to take what they publish with a pinch of salt.
Hardboy
08 Nov 2016
Re: Good Motley Fool review. It does not explain the different levels of fall, and the fact that Hikma was on a ski-slope while Glaxo was still rising before October. And to say a strengthening sterling is hurting both is a bit of a dream. The pound may have stopped falling, but it's hardly back where it was pre brexit. I think MF articles are fine so long as you understand how they are written - usually it is to illustrate a single simple point, which ignores a lot of other factors.
